News
HTSUF
29.00
NaN%
--
Taiyo Kosan Wins Control of Hisamitsu Pharmaceutical After Successful Tender Offer
TipRanks · 02/20 04:53
Hisamitsu Sets Record Date for Potential MBO-Linked Shareholder Meeting
TipRanks · 02/13 08:14
TAIYO KOSAN Amends Tender Offer Filing for Hisamitsu Pharmaceutical After U.S. Antitrust Waiting Period
TipRanks · 02/03 08:52
Hisamitsu President’s Vehicle TAIYO KOSAN Launches Tender Offer to Boost Stake
TipRanks · 01/07 10:22
Hisamitsu Board Backs CEO-Led MBO and Recommends Shareholders Tender Stock
TipRanks · 01/07 10:22
Hisamitsu Posts Modest Sales Growth, Withdraws Forecast as MBO and Delisting Loom
TipRanks · 01/06 14:31
Hisamitsu Pharmaceutical Scraps Year-End Dividend as Board Backs Privatization Tender Offer
TipRanks · 01/06 14:31
Hisamitsu Withdraws Earnings Forecast Amid MBO-Linked Tender Offer and Planned Delisting
TipRanks · 01/06 14:30
Hisamitsu Pharmaceutical Completes Share Buyback Initiative
TipRanks · 11/20/2025 06:55
Hisamitsu Pharmaceutical Advances Share Buyback Strategy
TipRanks · 11/06/2025 07:10
Hisamitsu Pharmaceutical Reports Q2 Financial Results and Increased Dividend Forecast
Barchart · 10/10/2025 02:08
Hisamitsu Pharmaceutical Announces Share Buyback Progress
Barchart · 10/04/2025 02:06
Hisamitsu Pharmaceutical Co (HTSUF) Gets a Hold from Nomura
TipRanks · 09/25/2025 11:55
Weekly Report: what happened at HTSUF last week (0908-0912)?
Weekly Report · 09/15/2025 10:33
Weekly Report: what happened at HTSUF last week (0901-0905)?
Weekly Report · 09/08/2025 10:35
Hisamitsu Pharmaceutical Advances Share Buyback Strategy
TipRanks · 09/03/2025 06:53
Weekly Report: what happened at HTSUF last week (0825-0829)?
Weekly Report · 09/01/2025 10:31
Weekly Report: what happened at HTSUF last week (0818-0822)?
Weekly Report · 08/25/2025 10:38
More
Webull provides a variety of real-time HTSUF stock news. You can receive the latest news about Hisamitsu Pharmaceutical Co In through multiple platforms. This information may help you make smarter investment decisions.
About HTSUF
Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.